clinical glycomics
translation of glycomic clinical biomarkers
clinical exploitation of glycomic biomarkers
translation of novel glycomics
glycomics profiles
Glycan Signatures
clinical chemists
clinical practice
Precision Medicine GlySign
innovative training
GlySign Consortium
research training network
Exploitation of Glycosylation Signatures
sensitive glycomics technologies
development of glycomics technology
important novel glycan biomarkers
diagnostic platforms
diagnostic tools
chronic diseases
variety of diseases
model diseases
field
disease progression
research programme
prostate cancer
analysis of samples
distinctive changes
current gap
translational focus
glycosylation of circulating proteins specific
high industrial-academic mobility
end users of GlySignâ€™s final products
subtype
discovery
neonatal alloimmune thrombocytopenia
healthy controls
close collaboration
major technical challenges
patients
diabetes
industry
immense structural complexity
great potential
human glycoproteins
academia
market
young scientists
lack of experts
rheumatoid arthritis
prognostic information
required glycoanalytical skills
glycans
advancement
range of selective
inflammatory conditions
clinicians
knowledge
beneficiaries